MoneyWorks4Me

Sanofi India - Quaterly Results

08 Nov 2023 Evaluate
The quarter ended September 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 7146.00 millions.Modest increase of 16.27% in the Net Profit was reported from. 1309.00 millions to Rs. 1522.00  millions.The company reported a good operating profit of 2203.00 millions compared to 1933.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202212 202112 % Var
Sales 7146.00 6919.00 3.28 21572.00 20982.00 2.81 27701.00 29566.00 -6.31
Other Income 118.00 114.00 3.51 533.00 515.00 3.50 715.00 744.00 -3.90
PBIDT 2203.00 1933.00 13.97 6699.00 5890.00 13.74 7759.00 8369.00 -7.29
Interest 3.00 5.00 -40.00 13.00 13.00 0.00 17.00 18.00 -5.56
PBDT 2200.00 1928.00 14.11 6864.00 7058.00 -2.75 9062.00 13243.00 -31.57
Depreciation 99.00 104.00 -4.81 294.00 319.00 -7.84 419.00 667.00 -37.18
PBT 2101.00 1824.00 15.19 6570.00 6739.00 -2.51 8643.00 12576.00 -31.27
TAX 579.00 515.00 12.43 1915.00 1842.00 3.96 2437.00 3132.00 -22.19
Deferred Tax -7.00 -12.00 -41.67 -22.00 20.00 -210.00 -15.00 -228.00 -93.42
PAT 1522.00 1309.00 16.27 4655.00 4897.00 -4.94 6206.00 9444.00 -34.29
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 30.83 27.94 10.35 31.05 28.07 10.62 28.01 28.31 -1.05
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..